[go: up one dir, main page]

UA94434C2 - Экстракт коры дерева рода corynanthe и его применение, лекарственное средство, пищевой продукт с лекарственными или профилактическими свойствами и фармацевтический препарат, который его содержит - Google Patents

Экстракт коры дерева рода corynanthe и его применение, лекарственное средство, пищевой продукт с лекарственными или профилактическими свойствами и фармацевтический препарат, который его содержит

Info

Publication number
UA94434C2
UA94434C2 UAA200807765A UAA200807765A UA94434C2 UA 94434 C2 UA94434 C2 UA 94434C2 UA A200807765 A UAA200807765 A UA A200807765A UA A200807765 A UAA200807765 A UA A200807765A UA 94434 C2 UA94434 C2 UA 94434C2
Authority
UA
Ukraine
Prior art keywords
extracts
bark
medicaments
corynanthe
pharmaceutical preparations
Prior art date
Application number
UAA200807765A
Other languages
English (en)
Ukrainian (uk)
Inventor
Егон Кох
Херманн Хауер
Original Assignee
Др. Виллмар Швабе Гмбх & Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Др. Виллмар Швабе Гмбх & Ко. Кг filed Critical Др. Виллмар Швабе Гмбх & Ко. Кг
Publication of UA94434C2 publication Critical patent/UA94434C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Данное изобретение касается экстрактов коры деревьев рода Corynanthe, а именно Corynanthe Pachyceras, а также их использования для лечения и профилактики заболеваний нижних отделов мочеиспускательных путей, сексуальных расстройств, нарушений метаболизма липидов, заболеваний сердечно-сосудистой системы и острых и хронических болевых состояний. Данное изобретение также касается лекарственных средств, диетических пищевых продуктов и фармацевтических композиций, которые содержат указанные экстракты.
UAA200807765A 2005-11-08 2006-11-07 Экстракт коры дерева рода corynanthe и его применение, лекарственное средство, пищевой продукт с лекарственными или профилактическими свойствами и фармацевтический препарат, который его содержит UA94434C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005053241A DE102005053241A1 (de) 2005-11-08 2005-11-08 Extrakte aus der Rinde von Corynanthe-Arten und deren Verwendung sowie diese Extrakte enthaltende Arzneimittel, diätetische Lebensmittel und pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
UA94434C2 true UA94434C2 (ru) 2011-05-10

Family

ID=37982546

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200807765A UA94434C2 (ru) 2005-11-08 2006-11-07 Экстракт коры дерева рода corynanthe и его применение, лекарственное средство, пищевой продукт с лекарственными или профилактическими свойствами и фармацевтический препарат, который его содержит

Country Status (12)

Country Link
US (1) US20090142428A1 (ru)
EP (1) EP1945238A2 (ru)
JP (1) JP5435951B2 (ru)
KR (1) KR101306599B1 (ru)
CN (1) CN101291682A (ru)
AU (1) AU2006312678B2 (ru)
BR (1) BRPI0618634A2 (ru)
CA (1) CA2624703A1 (ru)
DE (1) DE102005053241A1 (ru)
RU (1) RU2399378C2 (ru)
UA (1) UA94434C2 (ru)
WO (1) WO2007054269A2 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101683337B (zh) * 2008-09-27 2011-12-07 复旦大学 柯楠因在制备治疗心肌损伤性心脏病药物中的用途
JP2011125331A (ja) * 2009-11-17 2011-06-30 Taisho Pharmaceutical Co Ltd 魚鱗粉末含有コーティング錠剤
CN102002039B (zh) * 2010-11-12 2012-05-09 天医堂(厦门)生物工程有限公司 一种从育亨宾树皮中提取育亨宾的方法
CN102030747A (zh) * 2010-11-19 2011-04-27 陕西嘉禾植物化工有限责任公司 一种育亨宾碱的制备方法
EP3646871A1 (en) * 2018-10-30 2020-05-06 SEROJAC PME Handels GmbH Treatment and prevention of premature ejaculation (pe)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758049A (fr) * 1970-10-27 1971-04-01 Omnium Chimique Sa Produit pharmaceutique a proprietes hypotensives et sedatives et son procede d'obtention.
FR2112344A1 (en) * 1970-10-27 1972-06-16 Omnium Chimique Sa Hypotensive, sedative extract of pseudocni - chona africana
DE3204960A1 (de) * 1982-02-12 1983-08-25 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Corynanthein-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US6323211B1 (en) * 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
FR2765483B1 (fr) * 1997-07-04 2000-02-04 Philippe Gorny Medicament destine a traiter les dysfonctions erectiles
IT1293539B1 (it) * 1997-07-16 1999-03-01 Sigma Tau Ind Farmaceuti Composizione nutritiva per soggetti in stato di debilitazione causato da stress
ITMI20011237A1 (it) * 2001-06-12 2002-12-12 Enzo Leone Uso della yohimbina per la preparazione di farmaci ad attivita' immunobiologica

Also Published As

Publication number Publication date
AU2006312678B2 (en) 2013-03-28
EP1945238A2 (de) 2008-07-23
KR20080071172A (ko) 2008-08-01
WO2007054269A2 (de) 2007-05-18
RU2399378C2 (ru) 2010-09-20
CA2624703A1 (en) 2007-05-18
RU2008119965A (ru) 2009-12-20
US20090142428A1 (en) 2009-06-04
JP5435951B2 (ja) 2014-03-05
DE102005053241A1 (de) 2007-05-16
JP2009514916A (ja) 2009-04-09
WO2007054269A3 (de) 2007-08-09
CN101291682A (zh) 2008-10-22
AU2006312678A1 (en) 2007-05-18
BRPI0618634A2 (pt) 2011-09-06
KR101306599B1 (ko) 2013-09-10

Similar Documents

Publication Publication Date Title
Sharifi-Rad et al. Diet, lifestyle and cardiovascular diseases: linking pathophysiology to cardioprotective effects of natural bioactive compounds
Senoner et al. Oxidative stress in cardiovascular diseases: still a therapeutic target?
Caruso et al. Pomegranate: Nutraceutical with promising benefits on human health
Surai Silymarin as a natural antioxidant: an overview of the current evidence and perspectives
Davis et al. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance
del Pilar Sánchez-Camargo et al. Rosemary (Rosmarinus officinalis) as a functional ingredient: recent scientific evidence
Armeli et al. Mediterranean diet and neurodegenerative diseases: the neglected role of nutrition in the modulation of the endocannabinoid system
Wang et al. Apigenin inhibits the expression of IL-6, IL-8, and ICAM-1 in DEHP-stimulated human umbilical vein endothelial cells and in vivo
BRPI0418681A (pt) um suplemento dietético para o tratamento e a prevenção de doenças do sistema digestivo e doenças relacionadas ao sistema digestivo e método de produção e administração deste
MX2010003651A (es) Composiciones de lipido para el tratamiento de desordenes gastrointestinales y la promocion del desarrollo y maduracion intestinal.
NO20074318L (no) Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer
Pesce et al. Phytotherapics in COVID19: Why palmitoylethanolamide?
Sá et al. Effects on liver lipid metabolism of the naturally occurring dietary flavone luteolin‐7‐glucoside
Dahiya Nutraceuticals and their impact on human health
George et al. An insight into the neuroprotective effects and molecular targets of pomegranate (Punica granatum) against Alzheimer’s disease
NO20083307L (no) Anvendelse av et ikke-forsapbart ekstrakt fra plantemasse ved behandling av hudaldring
Sadek et al. A coelomic fluid of allolobophora caliginosa as novel prospects for medicinal antioxidants, anti-inflammatory, antiproliferative, analgesics, and antipyretics
EP2050442A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF BONE DISORDERS, FUNCTIONAL FOOD OR HEALTH MEASURES CONTAINING THIS COMPOSITION AND PHARMACEUTICAL PREPARATION CONTAINING THE COMPOSITION AS AN ACTIVE SUBSTANCE
Ahmed et al. Premna odorata extract as a protective agent on neurotoxic effect of aluminum: neurochemical, molecular, and histopathological alterations
Abbas et al. Natural immunomodulators treat the cytokine storm in SARS-CoV-2
Ullah et al. Epigenetic drug development for autoimmune and inflammatory diseases
TW200612903A (en) Use of trisubstituted benzopyranones
UA94434C2 (ru) Экстракт коры дерева рода corynanthe и его применение, лекарственное средство, пищевой продукт с лекарственными или профилактическими свойствами и фармацевтический препарат, который его содержит
Kacemi et al. Bee Pollen as a Source of Pharmaceuticals: Where Are We Now?
BRPI0413714A (pt) frações de leite e preparações de leite para tratamento e/ou prevenção de doenças mediadas por cox-2